Вход на сайт
COVID-19: лечение и профилактика
67505 просмотров
Перейти к просмотру всей ветки
Назад
в ответ pfeiferm1966 03.03.21 09:41
Findings In this randomized clinical trial that included 476 patients, the duration of symptoms was not significantly different for patients who received a 5-day course of ivermectin compared with placebo (median time to resolution of symptoms, 10 vs 12 days; hazard ratio for resolution of symptoms, 1.07).
Meaning The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand effects on other clinically relevant outcomes.